Gliknik receives $15M payment from Pfizer after reaching clinical milestone - Technical.ly Baltimore

Sciences

Feb. 19, 2019 1:26 pm

Gliknik receives $15M payment from Pfizer after reaching clinical milestone

The University of Maryland BioPark company's candidate drug is being developed to treat a rare neurological disorder.

Baltimore's BioPark is part of the University System of Maryland.

(Courtesy photo)

Baltimore biopharmaceutical startup Gliknik said human trials began for a candidate drug it’s developing to treat a rare neurological disorder.

With the beginning of the Phase I clinical trial, the University of Maryland BioPark-based company received a $15 million payment from pharmaceutical giant Pfizer. The payment is tied to a licensing deal between the company and Pfizer, which was initially inked in 2013.

Gliknik is developing a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP), which the company said is not derived from blood. It’s designed to meet the effectiveness of a blood product called Intravenous Immune Globulin, which is used to treat autoimmune diseases. Previously, the candidate received orphan drug designation from the U.S. Food and Drug Administration in 2015.

“Beginning the Phase I clinical trial is an important milestone in the development of this drug candidate,” said Gliknik CEO David S. Block in a statement. “We are hopeful that Pfizer’s clinical development efforts will lead to more treatment options for patients with CIDP.”

Under the licensing deal, Pfizer could also receive royalties on sales if the products are commercialized.

Companies: Gliknik, Pfizer
-30-
JOIN THE COMMUNITY, BECOME A MEMBER
Already a member? Sign in here

Advertisement

Vixiar Medical raises $1.5M, reports progress on heart failure monitoring device

BurnAlong raises $1.5M, moves to new offices in Pikesville

3 things we learned mapping Baltimore’s startup ecosystem

SPONSORED

Baltimore

At 14 West, only go-getters need apply

Baltimore, MD

SmartLogic

Product Designer

Apply Now
Baltimore, MD 21201

Agora Financial

Jr. Project Manager / Business Analyst

Apply Now
Baltimore, MD

SmartLogic

Developer

Apply Now

Hanover’s Dragos looks to grow with a Houston office and an Atlanta acquisition

Where Baltimore factored into that ’60 Minutes’ feature on Rise of the Rest

Humans of NET/WORK: How 5 job fair goers want to move up in Baltimore

SPONSORED

Baltimore

Learn to lead digital transformation at Phorum 2019

Baltimore

Mindgrub

Automation Engineer

Apply Now
1629 Thames Street Suite 400 Baltimore, MD 21231

Contrast Security

Software Engineer Java

Apply Now
1629 Thames Street, Suite 400 Baltimore, MD 21231

Contrast Security

Software Engineer Ruby

Apply Now

Sign-up for daily news updates from Technical.ly Baltimore

Do NOT follow this link or you will be banned from the site!